Patent Rule Limits Applications, Impacting Device Makers’ Filing Strategies
This article was originally published in The Gray Sheet
Executive Summary
A highly anticipated final 1rule from the U.S. Patent and Trademark Office puts new limits on the number of applications a company can file for any single invention, potentially requiring changes in device manufacturers' patent strategies
You may also be interested in...
Rule Limiting Patent Application Filings Is Officially Off The Table
The U.S. Patent and Trademark Office rescinded a set of controversial regulations intended to cap certain patent application filings in a revised final 1rule released Oct. 14
Rule Limiting Patent Application Filings Is Officially Off The Table
The U.S. Patent and Trademark Office rescinded a set of controversial regulations intended to cap certain patent application filings in a revised final 1rule released Oct. 14
Industry Takes Round 1 In Patent Office Rule Dispute, Gets Temporary Hold
GlaxoSmithKline won a reprieve for life science industries when a federal court agreed to temporarily halt implementation of new patent rules that would have limited the number of continuation applications a patent holder can file